76
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

, , , , , , , , , & show all
Pages 2167-2176 | Published online: 24 Oct 2018

References

  • GassJDPathogenesis of disciform detachment of the neuroepitheliumAm J Ophthalmol19676331139
  • NicholsonBNobleJForooghianFMeyerleCCentral serous chorioretinopathy: update on pathophysiology and treatmentSurv Ophthalmol201358210312623410821
  • LiewGQuinGGilliesMFraser-BellSCentral serous chorioretinopathy: a review of epidemiology and pathophysiologyClin Exp Ophthalmol201341220121422788735
  • FujimotoHGomiFWakabayashiTMorphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomographyOphthalmology20081159149415001500.e1218394706
  • BreukinkMBDingemansAJden HollanderAIChronic central serous chorioretinopathy: long-term follow-up and vision-related quality of lifeClin Ophthalmol201711394628053499
  • WangMMunchICHaslerPWPrünteCLarsenMCentral serous chorioretinopathyActa Ophthalmol200886212614517662099
  • DaruichAMatetADiraniACentral serous chorioretinopathy: Recent findings and new physiopathology hypothesisProg Retin Eye Res2015488211826026923
  • QuinGLiewGHoIVGilliesMFraser-BellSDiagnosis and interventions for central serous chorioretinopathy: review and updateClin Exp Ophthalmol201341218720022788713
  • GemenetziMde SalvoGLoteryAJCentral serous chorioretinopathy: an update on pathogenesis and treatmentEye201024121743175620930852
  • YannuzziLAType A behavior and central serous chorioretinopathyTrans Am Ophthalmol Soc1986847998453590481
  • HaimoviciRKohSGagnonDRRisk factors for central serous chorioretinopathy: a case-control studyOphthalmology2004111224424915019370
  • de JongEKBreukinkMBSchellevisRLChronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degenerationOphthalmology2015122356257025439433
  • MikiAKondoNYanagisawaSCommon variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathyOphthalmology201412151067107224365176
  • SchubertCPrydsAZengSCadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyHum Mutat201435785986724665005
  • BreukinkMBSchellevisRLBoonCJGenomic copy number variations of the complement component C4B gene are associated with chronic central serous chorioretinopathyInvest Ophthalmol Vis Sci20155695608561326305533
  • SalehiMWenickASLawHAEvansJRGehlbachPInterventions for central serous chorioretinopathy: a network meta-analysisCochrane Database Syst Rev20152212CD011841
  • van DijkEHCFauserSBreukinkMBHalf-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE TrialOphthalmology2018125101547155529776672
  • PiccolinoFCde La LongraisRRManeaMCicinelliSPosterior cystoid retinal degeneration in central serous chorioretinopathyRetina20082871008101218698305
  • IidaTYannuzziLASpaideRFCystoid macular degeneration in chronic central serous chorioretinopathyRetina2003231137138
  • von WinningCHOosterhuisJARenger-van DijkAHHornstra-LimburgHPolakBCDiffuse retinal pigment epitheliopathyOphthalmologica198218517147099547
  • YannuzziLASlakterJSKaufmanSRGuptaKLaser treatment of diffuse retinal pigment epitheliopathyEur J Ophthalmol1992231031141450655
  • MohabatiDvan RijssenTJvan DijkEHClinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathyClin Ophthalmol2018121061107029922035
  • PolakBCBaarsmaGSSnyersBDiffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatmentBr J Ophthalmol199579109229257488581
  • GregoriNZFeuerWRosenfeldPJNovel method for analyzing snellen visual acuity measurementsRetina20103071046105020559157
  • OtsukaSOhbaNNakaoKA long-term follow-up study of severe variant of central serous chorioretinopathyRetina2002221253211884874
  • LooRHScottIUFlynnHWFactors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathyRetina2002221192411884873
  • BalaratnasingamCFreundKBTanAMBullous variant of central serous chorioretinopathy: expansion of phenotypic features using multimethod imagingOphthalmology201612371541155227084564
  • FujitaKImamuraYShinodaKOne-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathyOphthalmology2015122355556125444637
  • LimJIGlassmanARAielloLPCollaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathyOphthalmology201412151073107824439758
  • NicolóMEandiCMAlovisiCHalf-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathyAm J Ophthalmol201415751033103724487046
  • SilvaRMRuiz-MorenoJMGomez-UllaFPhotodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up studyRetina201333230931523095766
  • AgrawalRChhablaniJTanKAShahSSarvaiyaCBankerAChoroidal vascularity index in central serous chorioretinopathyRetina20163691646165127124882
  • WarrowDJHoangQVFreundKBPachychoroid pigment epitheliopathyRetina20133381659167223751942
  • Castro-CorreiaJCoutinhoMFRosasVMaiaJLong-term follow-up of central serous retinopathy in 150 patientsDoc Ophthalmol19928143793861486812
  • YannuzziLAShakinJLFisherYLAltomonteMAPeripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathyOphthalmology19849112155415726084221
  • KimYKRyooNKWooSJParkKHComparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathyGraefes Arch Clin Exp Ophthalmol2015253122063207325616728
  • AlkinZPerenteIOzkayaAComparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathyClin Ophthalmol2014868569024741287